TDM6: Comparison of the 6-minute Walking Test in a Corridor and on a Non-motorized Treadmill

Sponsor
Hopital Foch (Other)
Overall Status
Completed
CT.gov ID
NCT04541511
Collaborator
(none)
9
1
2
18
0.5

Study Details

Study Description

Brief Summary

Evaluation of the equivalence of 6-minute walking test performed on a non-motorized treadmill to the reference test : a 6-minute walking test on a corridor.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: 6-minutes walking test on a corridor
  • Diagnostic Test: 6-minutes walking test on a treadmill
N/A

Detailed Description

The Six-Minute Walk Test (6-WT) is a standardized test to assess a person's functional ability to walk as far as they can in six minutes. It is widely used in the assessment of functional disability in response to medical intervention in respiratory and cardiac conditions.

This test requires a corridor measuring between 20 and 30 metres and does not require any special technical equipment or training.

While the test appears simple to set up, factors such as the length or width of the corridor, and external disruptive elements, may affect the results. Indeed, the configuration of the test site plays a role in the test result. For example, the distance traveled in a 6-minute walking test is greater on a continuous circuit than in a lane that requires people to walk back and forth or when others are using the lane (zigzags, slowdowns). In a hospital setting, while it is easy to find a corridor that is long enough, it is not always possible to dedicate it exclusively to walking tests.

An alternative would be to perform this test on a non-motorized treadmill to avoid these biases. The main objective of this study is to evaluate the equivalence of a 6-minute walking test performed on a non-motorized treadmill to the reference test in healthy subjects. In addition, a small number of patients will be invited to perform a 6-minute CT scan on a non-motorized treadmill in order to first evaluate the perception and acceptability of this new method in this population (seniors, pathologies). If the results are conclusive, a similar study with patients only will be performed.

Study Design

Study Type:
Interventional
Actual Enrollment :
9 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
31 healthy subjects 6 patients31 healthy subjects 6 patients
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Comparison of the 6-minute Walking Test in a Corridor and on a Non-motorized Treadmill, Feasibility Study
Actual Study Start Date :
Aug 28, 2020
Actual Primary Completion Date :
Feb 26, 2022
Actual Study Completion Date :
Feb 27, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Healthy subject

Healthy subject will be asked to performed two 6-minutes walking test : one in a corridor and one on the non-motorized treadmill. Oxygen saturation, heart rate and Borg score will be collected before and after each test.

Diagnostic Test: 6-minutes walking test on a corridor
6-minutes walking test on a corridor : patient will be asked to achieve the longest possible distance without running. He/she will be allowed to take breaks if he/she feels the need to do so.

Diagnostic Test: 6-minutes walking test on a treadmill
6-minutes walking test on a treadmill : patient will be asked to achieve the longest possible distance without running on the treadmill. He/she will be allowed to take breaks if he/she feels the need to do so.

Experimental: Patients

Patients will be asked to to performed a 6-minutes walking test on the non-motorized treadmill and to answer a questionnaire regarding the acceptability and ease of use of the new method.

Diagnostic Test: 6-minutes walking test on a treadmill
6-minutes walking test on a treadmill : patient will be asked to achieve the longest possible distance without running on the treadmill. He/she will be allowed to take breaks if he/she feels the need to do so.

Outcome Measures

Primary Outcome Measures

  1. To assess the equivalence of walking distances obtained with the 6-minute walk test on a non-motorized treadmill to the baseline (6-WT on a corridor) test in healthy subjects. [[length on the test - 1 day]]

    Total distance on the 6-WT on a corridor and on a non-motorized treadmill in healthy subjects.

Secondary Outcome Measures

  1. Evaluate the change in heart rate during the two test methods in healthy subjects [[length on the test - 1 day]]

    Heart rate before and after each test : 6-WT on a corridor and on a non-motorized treadmill in healthy subjects.

  2. Evaluate the change in oxygen saturation during the two test methods in healthy subjects. [[length on the test - 1 day]]

    Oxygen saturation before and after each test : 6-WT on a corridor and on a non-motorized treadmill in healthy subjects.

  3. To measure the perception of exertion after both test methods in healthy subjects. [[length on the test - 1 day]]

    Borg scale before and after each test : 6-WT on a corridor and on a non-motorized treadmill in healthy subjects.

  4. Evaluate patients' perception of the use of the new method. [[length on the test - 1 day]]

    Non-standardized questionnaire assessing the acceptability and ease of use of the new method

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy subject 18 years of age or older

  • Have signed a consent form

  • Be affiliated with a Health Insurance Plan

  • Having a pathology requiring the monitoring of the evolution of the distance performed by 6-WT (patients only)

Exclusion Criteria:
  • Being unable to walk for several minutes for physical, neurological or psychological reasons

  • Recent acute coronary syndrome

  • Rest tachycardia greater than 120 pulses/min.

  • Resting blood pressure greater than 180/100 mmHg

  • Pregnant, Parturient or Nursing Women

  • Persons deprived of liberty: minors or adults who are subject to a legal protection measure or who are unable to express their consent.

  • Subjects under guardianship or curatorship.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hopital Foch Suresnes Ile-de-France France 92150

Sponsors and Collaborators

  • Hopital Foch

Investigators

  • Principal Investigator: Nina GOUDIER, Hopital Foch

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hopital Foch
ClinicalTrials.gov Identifier:
NCT04541511
Other Study ID Numbers:
  • 2020_0047
First Posted:
Sep 9, 2020
Last Update Posted:
Aug 3, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hopital Foch
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 3, 2022